# Using IVR to Maintain ACS Patients on Best Practice Guidelines

Study · id `cardio:ct-nct01260207` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01260207](<https://clinicaltrials.gov/study/NCT01260207>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01260207

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 654 participants.

## Technical summary

Registry record NCT01260207. Randomized; single masking; primary purpose treatment. Start 2010-01 (actual); primary completion 2014-12-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 654 participants (enrolled count; ClinicalTrials.gov record NCT01260207, source copy `cardio:ctgov-nct01260207-2017-08-28`, retrieved 2026-10-31)
- Started: 2010-01 (actual) (ClinicalTrials.gov record NCT01260207, source copy `cardio:ctgov-nct01260207-2017-08-28`, retrieved 2026-10-31)
- Primary completion: 2014-12-15 (actual) (ClinicalTrials.gov record NCT01260207, source copy `cardio:ctgov-nct01260207-2017-08-28`, retrieved 2026-10-31)
- Completion: 2014-12-15 (actual) (ClinicalTrials.gov record NCT01260207, source copy `cardio:ctgov-nct01260207-2017-08-28`, retrieved 2026-10-31)
- Countries: Canada (ClinicalTrials.gov record NCT01260207, source copy `cardio:ctgov-nct01260207-2017-08-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01260207-2017-08-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Using IVR to Maintain ACS Patients on Best Practice Guidelines
- Acronym: IVR-ACS BPG
- Condition: Acute Coronary Syndrome
- Condition: Medication Adherence
- Intervention (Other): IVR group
- Lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Lead sponsor class: OTHER
- Collaborator: Ottawa Heart Institute Research Corporation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (`cardio:org-london-health-sciences-centre-research-institute-or-lawson-92e6ca`)
- Registry lists this organization as a collaborator: Ottawa Heart Institute Research Corporation (`cardio:org-ottawa-heart-institute-research-corporation`)

## Provenance

Content hash: 8f1605a4836395363af3f96f57ad096e6a52e66af9065de0596e5b6e345e0acf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
